UBS analyst Joshua Spector downgraded Diversey to Neutral from Buy with a price target of $8.40, down from $8.50. The company has accepted the Solenis offer of $8.40 per share in cash for public holders, which allows for a faster exit for majority holder Bain, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on DSEY: